Clinical trials: Contrast-enhanced US
Magnetic Resonance Imaging, Hepatocellular Carcinoma
Improving Hepatocellular Carcinoma Screening
This is a monocentric, single blind, interventional, single arm study. It is designed to compare the rates of detection of hepatocellular carcinoma (HCC) by ultrasound (US) used in clinical routine vs.
- Conditions
- Magnetic Resonance Imaging, Hepatocellular Carcinoma, Screening, Contrast-enhanced US
- Trial name
- AMRIK (NCT05828446)
- Testing
- MRI
- Where
- Switzerland
- Volunteers
- 330 people
- Sponsor
- Naik Vietti Violi